Double Peak Group

Double Peak Group is a pioneering venture capital firm and family office established in 2017, headquartered in Hong Kong. The firm focuses on investments within the rapidly evolving digital asset and blockchain sectors. They adopt a value investing philosophy, making strategic investments with a long-term perspective in early funding rounds and secondary markets. Double Peak Group aims to support visionary founders in their quest to reshape the future by facilitating change and fostering progress through technological advancement.

The firm was founded by Galen Law-Kun, whose family wealth originated from early cryptocurrency investments. This background provides Double Peak Group with a deep understanding and agility in navigating the digital asset landscape. The team comprises experts with diverse backgrounds in investment banking, private equity, and entrepreneurship, bringing a unique blend of financial expertise and business acumen to their investment approach.

Double Peak Group's investment focus is broad within the digital asset space, encompassing areas such as asset management, banking and payments, cross-chain platforms, CeFi-DeFi bridges, infrastructure protocols, investment funds, gaming/NFTs, privacy/security, the metaverse, and trading and exchanges. Beyond digital assets, the firm also shows interest in robotics, brain-computer interface, embodied intelligence, and aviation and aerospace. They have made numerous investments in companies across these sectors, including Watr, Novastro, Surge, Gameplan, Covalent Research & Development, CUDOS, Lunaverse, Defiato, Chainport, Heroes of Mavia, Engines of Fury, and Solvent.

The firm's commitment extends beyond capital, acting as partners and mentors to the founders they back. They conduct comprehensive due diligence and embrace a contrarian approach, often being early adopters in promising territories, particularly within Asia's thriving ecosystem. Double Peak Group operates under Nyx Holdings, the family office of Mr. Galen Law-Kun, deploying patient, value-focused capital.